Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00672802 · ClinicalTrials.gov registry record · Phase 2
Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease
A Phase 2 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 2
- Development phase
- 26
- Enrollment target
NCT00672802: Completed Phase 2 study, sponsored by Takeda.
NCT00672802 is a Phase 2 study that has completed, run by Takeda. The registered enrollment target is 26 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00672802, a Phase 2 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 26 participants
- Enrollment target
Study Summary
This purpose of this study is to assess the safety of ramelteon, once daily (QD), in subjects with chronic obstructive pulmonary disease.
Interventions
- DRUG Ramelteon and Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2003-08 |
| Est. Completion | 2004-03 |
| Phase | Phase 2 |
What the finished NCT00672802 record still lists
NCT00672802 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 1 intervention - of which Ramelteon and Placebo is the first listed.
NCT00672802 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00672802 about?
NCT00672802 is a clinical study titled "Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease". This purpose of this study is to assess the safety of ramelteon, once daily (QD), in subjects with chronic obstructive pulmonary disease.
What is the current status of trial NCT00672802?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 26 participants. The study started on 2003-08. Estimated completion is 2004-03.
What interventions are being tested in trial NCT00672802?
The interventions under investigation include: Ramelteon and Placebo (DRUG).
Who is sponsoring clinical trial NCT00672802?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00672802's enrollment target sits among peer trials
26 1708th of 2000 higher than 282 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia